HIV-1 Protein Nef Inhibits Activity of ATP-binding Cassette Transporter A1 by Targeting Endoplasmic Reticulum Chaperone Calnexin*
暂无分享,去创建一个
Anastas Popratiloff | M. Bukrinsky | D. Sviridov | L. Dubrovsky | A. Popratiloff | M. Fitzgerald | Lucas Jennelle | Ruth Hunegnaw | Larisa Dubrovsky | Tatiana Pushkarsky | Michael L Fitzgerald | Dmitri Sviridov | Beda Brichacek | Michael Bukrinsky | T. Pushkarsky | Ruth Hunegnaw | Lucas T Jennelle | B. Brichacek | Tatiana Pushkarsky
[1] D. Y. Thomas,et al. Saccharomyces cerevisiae CNE1 Encodes an Endoplasmic Reticulum (ER) Membrane Protein with Sequence Similarity to Calnexin and Calreticulin and Functions as a Constituent of the ER Quality Control Apparatus (*) , 1995, The Journal of Biological Chemistry.
[2] F. Kashanchi,et al. Stimulation of the Liver X Receptor Pathway Inhibits HIV-1 Replication via Induction of ATP-Binding Cassette Transporter A1 , 2010, Molecular Pharmacology.
[3] S. Yokoyama,et al. Effects of Mutations of ABCA1 in the First Extracellular Domain on Subcellular Trafficking and ATP Binding/Hydrolysis* 210 , 2003, The Journal of Biological Chemistry.
[4] J. Caramelo,et al. Getting In and Out from Calnexin/Calreticulin Cycles* , 2008, Journal of Biological Chemistry.
[5] J. Badimón,et al. Cardiovascular implications of HIV-induced dyslipidemia. , 2011, Atherosclerosis.
[6] H. Low,et al. Cholesterol efflux assay. , 2012, Journal of visualized experiments : JoVE.
[7] B. Peterlin,et al. Structure–function relationships in HIV‐1 Nef , 2001, EMBO reports.
[8] I. Braakman,et al. Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. , 2001, Biochimie.
[9] D. Keppler,et al. Reconstitution of Transport-Active Multidrug Resistance Protein 2 (MRP2; ABCC2) in Proteoliposomes , 2002, Biological chemistry.
[10] Angela Grant,et al. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. , 2010, Biochemistry.
[11] B. Moss,et al. Calreticulin Interacts with Newly Synthesized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, Suggesting a Chaperone Function Similar to That of Calnexin (*) , 1996, The Journal of Biological Chemistry.
[12] R. Swanstrom,et al. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo , 1993, Journal of virology.
[13] D. Clarke,et al. Prolonged association of temperature-sensitive mutants of human P-glycoprotein with calnexin during biogenesis. , 1994, The Journal of biological chemistry.
[14] F. Kirchhoff,et al. Human Immunodeficiency Virus Type 1 Inhibits DNA Damage-Triggered Apoptosis by a Nef-Independent Mechanism , 2005, Journal of Virology.
[15] J. Riordan,et al. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. , 1994, The Journal of biological chemistry.
[16] M. Simm,et al. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes , 1995, Journal of virology.
[17] K. Collins,et al. Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways , 2006, Microbiology and Molecular Biology Reviews.
[18] M. Suico,et al. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. , 2003, Molecular biology of the cell.
[19] F. Momburg,et al. Multiple Residues in the Transmembrane Helix and Connecting Peptide of Mouse Tapasin Stabilize the Transporter Associated with the Antigen-processing TAP2 Subunit* , 2007, Journal of Biological Chemistry.
[20] T. Nagase,et al. Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjögren's Syndrome. , 2001, Biochemical and biophysical research communications.
[21] K. J. Henley,et al. ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis. , 2013, Cell metabolism.
[22] F. Kashanchi,et al. Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection. , 2012, Biochemical and biophysical research communications.
[23] Tracey M. Filzen,et al. HIV-1 Nef Disrupts Intracellular Trafficking of Major Histocompatibility Complex Class I, CD4, CD8, and CD28 by Distinct Pathways That Share Common Elements , 2011, Journal of Virology.
[24] R. Lempicki,et al. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux , 2012, Lipids in Health and Disease.
[25] M. Bukrinsky,et al. The ABCA1 domain responsible for interaction with HIV-1 Nef is conformational and not linear. , 2014, Biochemical and biophysical research communications.
[26] Y. Liu,et al. Dissecting glycoprotein quality control in the secretory pathway. , 2001, Trends in biochemical sciences.
[27] I. Tabas,et al. ABCA1-mediated Cholesterol Efflux Is Defective in Free Cholesterol-loaded Macrophages , 2002, The Journal of Biological Chemistry.
[28] M. Jackson,et al. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. , 1996, The EMBO journal.
[29] Xiao-Fang Yu,et al. Characterization of the Biosynthesis of Human Immunodeficiency Virus Type 1 Env from Infected T-cells and the Effects of Glucose Trimming of Env on Virion Infectivity* , 2001, The Journal of Biological Chemistry.
[30] S. Matsushita,et al. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope , 1988, Journal of virology.
[31] S. Reddy,et al. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms , 2011, Nature Reviews Cardiology.
[32] M. R. Leach,et al. Localization of the Lectin, ERp57 Binding, and Polypeptide Binding Sites of Calnexin and Calreticulin* , 2002, The Journal of Biological Chemistry.
[33] M. Robert-Guroff,et al. Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. A. Peterson,et al. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains , 1996, The Journal of experimental medicine.
[35] U. Danilczyk,et al. The Lectin Chaperone Calnexin Utilizes Polypeptide-based Interactions to Associate with Many of Its Substrates in Vivo * , 2001, The Journal of Biological Chemistry.
[36] R. Xavier,et al. SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter. , 2008, Biochemistry.
[37] H. Kusuhara,et al. Calreticulin facilitates the cell surface expression of ABCG5/G8. , 2006, Biochemical and biophysical research communications.
[38] K. Ueda,et al. The ABCA1 Q597R mutant undergoes trafficking from the ER upon ER stress. , 2008, Biochemical and biophysical research communications.
[39] D. Y. Thomas,et al. The Structure of calnexin, an ER chaperone involved in quality control of protein folding. , 2001, Molecular cell.
[40] M. Bukrinsky,et al. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. , 2010, The Journal of infectious diseases.
[41] M. Desvarieux,et al. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy , 2013, AIDS.
[42] R. Guieu,et al. Mapping of Domains on HIV Envelope Protein Mediating Association with Calnexin and Protein-disulfide Isomerase* , 2010, The Journal of Biological Chemistry.